Pulmonx Corp Stock Analysis

LUNG Stock  USD 3.78  0.54  16.67%   
Pulmonx Corp is overvalued with Real Value of 3.23 and Hype Value of 3.78. The main objective of Pulmonx Corp stock analysis is to determine its intrinsic value, which is an estimate of what Pulmonx Corp is worth, separate from its market price. There are two main types of Pulmonx Corp's stock analysis: fundamental analysis and technical analysis.
The Pulmonx Corp stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Pulmonx Corp's ongoing operational relationships across important fundamental and technical indicators.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.

Pulmonx Stock Analysis Notes

About 91.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.65. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pulmonx Corp recorded a loss per share of 1.44. The entity had not issued any dividends in recent years. Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California. Pulmonx Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 253 people. To find out more about Pulmonx Corp contact Steven Williamson at 650 364 0400 or learn more at https://pulmonx.com.

Pulmonx Corp Investment Alerts

Pulmonx Corp generated a negative expected return over the last 90 days
Pulmonx Corp has high historical volatility and very poor performance
Pulmonx Corp has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 83.79 M. Net Loss for the year was (56.39 M) with profit before overhead, payroll, taxes, and interest of 64.27 M.
Pulmonx Corp currently holds about 162.09 M in cash with (31.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.35, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 91.0% of the company shares are owned by institutional investors

Pulmonx Corp Upcoming and Recent Events

28th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Pulmonx Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 130.43 M.

Pulmonx Profitablity

The company has Profit Margin (PM) of (0.65) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.65) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.65.

Technical Drivers

As of the 23rd of July, Pulmonx Corp holds the Variance of 33.53, coefficient of variation of (1,731), and Risk Adjusted Performance of (0.04). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pulmonx Corp, as well as the relationship between them. Please check Pulmonx Corp variance and potential upside to decide if Pulmonx Corp is priced some-what accurately, providing market reflects its current price of 3.78 per share. Given that Pulmonx Corp has information ratio of (0.1), we recommend you to check out Pulmonx Corp's recent market performance to make sure the company can sustain itself at a future point.

Pulmonx Corp Price Movement Analysis

Execute Study
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Pulmonx Corp middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Pulmonx Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Pulmonx Corp Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pulmonx Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pulmonx Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Pulmonx Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Ferrari Richard over a month ago
Disposition of 8000 shares by Ferrari Richard of Pulmonx Corp at 3.16 subject to Rule 16b-3
 
Geoffrey Rose over two months ago
Disposition of 1724 shares by Geoffrey Rose of Pulmonx Corp at 6.97 subject to Rule 16b-3
 
Glendon French over two months ago
Disposition of 20000 shares by Glendon French of Pulmonx Corp at 6.52 subject to Rule 16b-3
 
Geoffrey Rose over three months ago
Disposition of 410 shares by Geoffrey Rose of Pulmonx Corp at 6.71 subject to Rule 16b-3
 
Geoffrey Rose over three months ago
Disposition of 2327 shares by Geoffrey Rose of Pulmonx Corp at 7.14 subject to Rule 16b-3
 
Glendon French over three months ago
Disposition of 20000 shares by Glendon French of Pulmonx Corp at 7.85 subject to Rule 16b-3
 
Glendon French over three months ago
Disposition of 2221 shares by Glendon French of Pulmonx Corp at 6.5 subject to Rule 16b-3
 
Glendon French over six months ago
Disposition of 2221 shares by Glendon French of Pulmonx Corp at 6.5 subject to Rule 16b-3
 
Geoffrey Rose over six months ago
Disposition of 1184 shares by Geoffrey Rose of Pulmonx Corp at 10.6 subject to Rule 16b-3
 
Geoffrey Rose over six months ago
Acquisition by Geoffrey Rose of 69100 shares of Pulmonx Corp at 9.3 subject to Rule 16b-3
 
Geoffrey Rose over six months ago
Disposition of 1184 shares by Geoffrey Rose of Pulmonx Corp at 10.6 subject to Rule 16b-3
 
Glendon French over six months ago
Disposition of 20000 shares by Glendon French of Pulmonx Corp at 6.52 subject to Rule 16b-3

Pulmonx Corp Outstanding Bonds

Pulmonx Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pulmonx Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pulmonx bonds can be classified according to their maturity, which is the date when Pulmonx Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Pulmonx Corp Predictive Daily Indicators

Pulmonx Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Pulmonx Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Pulmonx Corp Forecast Models

Pulmonx Corp's time-series forecasting models are one of many Pulmonx Corp's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pulmonx Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Pulmonx Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pulmonx Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pulmonx shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pulmonx Corp. By using and applying Pulmonx Stock analysis, traders can create a robust methodology for identifying Pulmonx entry and exit points for their positions.
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California. Pulmonx Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 253 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Pulmonx Corp to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Technical Analysis Now

   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module

Complementary Tools for Pulmonx Stock analysis

When running Pulmonx Corp's price analysis, check to measure Pulmonx Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulmonx Corp is operating at the current time. Most of Pulmonx Corp's value examination focuses on studying past and present price action to predict the probability of Pulmonx Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulmonx Corp's price. Additionally, you may evaluate how the addition of Pulmonx Corp to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
FinTech Suite
Use AI to screen and filter profitable investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments